Real Chemistry announced a pair of senior hires on Thursday, highlighted by the appointment of IPG and Omnicom alum Jeff ...

In an interview with Campaign Germany, the 80-year-old S4 Capital chief executive took aim at rivals, fielded questions about ...

Just over two years after establishing desmoidtumors.com, the drugmaker is teaming with Jennifer Fisher to empower patients.

BridgeBio’s ATTR cardiomyopathy drug, Attruby, achieved promising sales numbers in the weeks after its FDA approval.

Medicaid is complex. The $880 billion-a-year state-federal program offers health coverage to millions of disabled and ...

“When you have health insurance, you should have confidence that it’s going to cover your health care needs,” said Sen. Scott Wiener, the San Francisco Democrat who introduced the bill. “They can just ...

Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...

In an interview with Campaign Germany, the 80-year-old S4 Capital chief executive took aim at rivals, fielded questions about his own holding company and made predictions about the future of adland.

In January, standing before a cluster of television cameras on the steps of the state Capitol, Georgia Gov. Brian Kemp promoted his experiment in Medicaid reform as a showcase for fellow conservatives ...

For now, U.S. public health officials face ebbing public trust as well as a disruptive new health administration led by skeptics of established medicine.

By registering you consent to the collection and use of your information to provide the products and services you have requested from us and as described in our privacy policy and terms and conditions ...

In a true David vs. Goliath battle, nimble independent agencies are defying the "bigger is better" narrative, winning top clients and industry awards with smart investments, speed, and agility.